Condensed Consolidated Statements of Earnings - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Net revenues	$ 7,123	$ 6,856	$ 19,849	$ 19,103
Cost of sales	1,961	1,915	5,909	5,367
Excise taxes on products	1,445	1,444	4,063	4,109
Gross profit	3,717	3,497	9,877	9,627
Marketing, administration and research costs	557	552	1,585	1,654
Asset impairment and exit costs	0	1	0	74
Operating income	3,160	2,944	8,292	7,899
Interest and other debt expense, net	310	293	893	989
Net periodic benefit income, excluding service cost	(3)	(24)	(58)	(40)
(Earnings) losses from equity investments	472	(333)	306	(866)
Impairment of JUUL equity securities	2,600	4,500	2,600	4,500
Loss on Cronos-related financial instruments	105	636	202	1,327
Earnings (losses) before income taxes	(324)	(2,128)	4,349	1,989
Provision for income taxes	632	474	1,817	1,473
Net earnings (losses)	(956)	(2,602)	2,532	516
Net (earnings) losses attributable to noncontrolling interests	4	2	11	0
Net earnings (losses) attributable to Altria	$ (952)	$ (2,600)	$ 2,543	$ 516
Per share data:
Basic earnings (losses) per share attributable to Altria (in usd per share)	$ (0.51)	$ (1.39)	$ 1.37	$ 0.27
Diluted earnings (losses) per share attributable to Altria (in usd per share)	$ (0.51)	$ (1.39)	$ 1.36	$ 0.27